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ABSTRACT
Objectives: To estimate the prevalence of
HIV-associated neurocognitive disorders (HAND) among
HIV patients in a multiethnic South Asian population,
describe the pattern of neurocognitive impairment in
HAND and the factors associated with HAND.
Design: A cross-sectional survey of HIV-positive
outpatients and inpatients.
Setting: The sole referral centre for HIV/AIDS
treatment in Singapore.
Participants: Inclusion criteria were HIV positive, age
between 21 and 80 years old and at least 3 years of
education. Exclusion criteria included concomitant
delirium, serious systemic disease or major psychiatric
illness. 265 patients did not meet criteria or declined to
participate. The ﬁnal sample size was 132.
Outcome measures: The primary outcome measure
was cognitive impairment based on performance on
the Montreal Cognitive Assessment, International HIV
Dementia Scale and Instrumental Activities of Daily
Living. The secondary outcome measure was the
classiﬁcation of impairment based on the 2007
updated research nosology for HAND.
Results: The prevalence of HAND was 22.7% of which
70% (15.9% of total) were asymptomatic
neurocognitive impairment, 23.3% (5.3% of total)
were mild neurocognitive disorder and 6.7% (1.5% of
total) were HIV-associated dementia. Increasing age
(OR 1.104, 95% CI 1.054 to 1.155, p<0.001), less
education (OR 0.78, 95% CI 0.69 to 0.89, p<0.001)
and low baseline CD4 count (OR 0.15, 95% CI 0.03 to
0.74, p¼0.019) were associated with HAND. Delayed
recall, language and abstract thinking were the
domains most commonly affected, but impairment in
visuospatial ability (RC 3.013, 95% CI 1.954 to 4.073,
p<0.001) and attention (RC 2.205, 95% CI 1.043 to
3.367, p<0.001) were most strongly associated with
HAND.
Conclusion: HAND is common among HIV patients in
a South Asian sample, most of whom are
asymptomatic. Older patients with less education and
severe illness at diagnosis are at highest risk of HAND.
Delayed recall is most commonly affected, but
visuospatial dysfunction is most strongly associated
with prevalent HAND.
INTRODUCTION
Much research attention has been given to
HIV-associated neurocognitive disorders
(HAND) in recent years because this entity
has taken on clinical importance now that
highly active antiretroviral therapy (HAART)
has achieved marked reductions in AIDS-
related morbidity and mortality. Majority of
the available data have emerged from
Western populations citing an incidence rate
of 21% and prevalence rates of up to 39%
1
with one study from the Asia-Paciﬁc region
reporting a prevalence of only 12%.
2 There is
a strong body of evidence showing an adverse
functional impact of HAND, with patients
having difﬁculty with activities of daily living
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ARTICLE SUMMARY
Article focus
- What is the prevalence of HIV-associated neuro-
cognitive disorders (HAND) in South Asia?
- What are the demographic and clinical charac-
teristics of South Asian individuals with HAND?
Key messages
- The estimated prevalence of HAND in South Asia
is high.
- Older patients with less education and more
severe HIV illness at diagnosis are at highest risk
for HAND.
- Early diagnosis of HIV and access to care and
treatment is essential.
Strengths and limitations of this study
- The article’s strengths are it is the ﬁrst study on
HAND in a representative multiethnic South Asian
population and it used a method of detection that
is applicable to local clinical practice.
- The limitations are the small sample size and
non-comparability with other HAND studies due
to different methods used in detection of HAND
cases.
- Another major limitation is the lack of published
local normative data on the tools used.
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Open Access Researchand requiring more assistance to ensure adherence to
medications.
3 They may even have difﬁculties main-
taining employment, hence requiring more social assis-
tance.
4 HAND has also been shown to be associated with
low nadir CD4 counts
1 in the absence of central nervous
system opportunistic infections and persists despite long-
standing suppression of viraemia.
5 With evidence that
HAART can improve neurocognitive functioning,
6 early
initiation of antiretroviral treatment in at-risk HIV-posi-
tive individuals may prevent neurocognitive impairment.
The prevalence of known HIV cases among the
Singapore resident population aged 15 years and above
was 0.1% in 2009.
7 There is a cumulative total of 4845
HIV-infected Singapore residents as of end 2010. In
2010, 54% of the newly diagnosed cases already had late-
stage HIV infection at the point of diagnosis, similar to
the pattern in previous years.
8 Due to the country’s strict
drug laws, intravenous drug abuse accounts for only 2%
of total cases. Previous local studies had identiﬁed older
age and lower baseline CD4 counts as predictors of
progression to AIDS
9 and that the commonest AIDS-
deﬁning illnesses between 1985 and 2001 did not involve
the central nervous system.
10 Despite a previous study
in South India that found mild-to-moderate neuro-
psychological deﬁcits in a functionally normal HIV-
positive group,
11 yet the total burden of HAND in
Singapore and other South Asian HIV-positive popula-
tions and its clinical signiﬁcance is so far unknown.
This is the ﬁrst study from a multiethnic South Asian
population to estimate the local prevalence of HAND and
to identify the demographic and clinical characteristics of
individuals with HAND. Our secondary objective is to test
the use of standardised cognitive screening and clinical
assessment tools for detecting HAND in our local setting.
METHODS
Study participants
This study was a cross-sectional survey conducted in the
Communicable Disease Centre of Singapore, which is
the country’s referral centre for care and treatment of
HIV/AIDS. Singapore has a multiethnic population
consisting of Chinese, Malay and Indian races and
represents a good reﬂection of the South Asian popu-
lation. The study protocol had been approved by the
Domain Speciﬁc Review Boards of the National Health-
care Group. The study was conducted from September
20 to October 15 of 2010 and included both inpatients
and outpatients. Patients were eligible if they were HIV
positive, aged between 21 and 80 years old and had at
least 3 years of education. Exclusion criteria included
patients with concomitant delirium, serious systemic
disease or major psychiatric illness. Written informed
consent was obtained from eligible patients.
Test battery
Participants were administered the Montreal Cognitive
Assessment (MoCA),
12 the International HIV Dementia
Scale (IHDS)
13 and the Lawton scale for Instrumental
Activities of Daily Living
14 by trained members of the
study team. The MoCA has been validated locally with
a cut-off score of 26/27 out of 30 for the diagnosis of
Mild Cognitive Impairment, but these data are currently
unpublished and under peer review (Ng, A et al, 2011)
The Instrumental Activities of Daily Living has also been
validated locally and shown to be cross-culturally appli-
cable.
15 However, the IHDS has not been validated
outside of Africa but has been used in India to screen for
HIV dementia in comparison with a HIV-negative
group.
13 16 As presence of depression was considered to
be a potential confounder, depressive symptoms were
measured by administering the Patient Health Ques-
tionnaire-9 on all participants.
17 18 To avoid interviewer
bias, study team members who administered the tests
were blinded to the clinical details at the time of
administering the cognitive tests. Patients were classiﬁed
as HAND or normal based on the clinical judgement of
impaired performance in at least two domains of delayed
recall, executive function, visuospatial function, atten-
tion, language function, abstract thought, orientation,
motor speed and psychomotor speed, in addition to
scores lower than recommended cut-offs on the MoCA
and IHDS, and information on functional impairment
which was ascertained using the stated instruments.
Hence, validated total cut-off scores on the MoCA and
IHDS were not used as the sole criterion of cognitive
impairment in the application of HAND criteria.
19
Demographic, relevant clinical data and laboratory data
were obtained by retrospective chart review. Data
included age, sex, acquisition risk for HIV, level of
education, concomitant sexually transmitted infections
and vascular risk factors such as hypertension, diabetes
and dyslipidemia, hepatitis B and C coinfection and
exposure variables of baseline CD4 cell count, current
CD4 cell count, stage of illness at diagnosis, length of
time since diagnosis, plasma HIV viral load and anti-
retroviral therapy.
Statistical analyses
Comorbid sexually transmitted infections and vascular
risk factors were analysed as categorical variables. Stage
of illness was deﬁned by the United States Center for
Disease Control classiﬁcation. CD4 counts were analysed
by three groups of severity: >500, 200e499 and <200.
Five participants with newly diagnosed illness and who
had only one set of laboratory results for CD4 counts had
the same data recorded for both baseline and current
CD4.
The prevalence of HAND and its subtypes was ﬁrst
computed. The Students t test and c
2 test were used to
compare continuous and categorical variables, respec-
tively, between cognitively normal and subjects with
HAND. Univariate logistic regression analysis was used to
determine the variables associated with HAND. Multi-
variate logistic regression analysis was then performed to
adjust for the effect of confounders. Subgroup analysis
was not performed as the numbers in the group with
the HAND outcome were insufﬁcient for meaningful
analysis.
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During the study period, 400 patients were screened for
eligibility. Two hundred and sixty-ﬁve patients either did
not meet the inclusion criteria or declined to participate.
Three were excluded because of concurrent delirium. A
total of 132 patients gave written informed consent to
participate in the study. Data from 132 participants were
analysed. 90.9% of the whole sample was receiving anti-
retroviral treatment. Data on the eligible patients that
did not participate are not available.
HAND was detected in 22.7% of the participants.
Within this group, 70% (15.9% of total) had asymp-
tomatic neurocognitive impairment, 23.3% (5.3% of
total) had mild neurocognitive disorder and 6.7% (1.5%
of total) had HIV-associated dementia. Table 1 shows the
demographic and clinical characteristics of the two
groups. HIV patients with HAND had a higher mean age
(54.40 vs 43.45, p<0.001) and lower mean years of
education (8.03 vs 11.45, p<0.001). Also, a larger
proportion of patients with HAND had more severe
stage of illness (stage C: 63.3% vs 31.4%, p¼0.006) and
lower baseline CD4 counts at diagnosis (CD4 <200:
80.0% vs 47.5%, p¼0.002). The two groups did not differ
signiﬁcantly in the presence of comorbid sexually
transmitted infections and vascular risk factors.
Univariate logistic regression analysis was performed
for all the exposure variables and it showed that age (OR
1.104, 95% CI 1.054 to 1.155, p<0.001), education (OR
0.78, 95% CI 0.69 to 0.89, p<0.001), stage C of illness
(OR 4.09, 95% CI 1.66 to 10.07, p¼0.002) and baseline
CD4 count between 200 and 499 (OR 10.00, 95% CI 2.23
to 44.92, p¼0.003) were signiﬁcantly associated with the
presence of HAND (table 2). Depression as measured
with the Patient Health Questionnaire-9 was found not
to be associated with HAND. The OR for a history of
central nervous system opportunistic infections was high
at 3.67, was 1.15 for the log-transformed viral load and
1.92 for the presence of any vascular risk factor but all
three were not statistically signiﬁcant. Therefore, multi-
variate logistic regression was used to adjust for the
confounders of age and education. Stage C of illness
ceased to be associated with the presence of HAND, and
the direction of association with a less severe baseline
CD4 became more consistent with clinical reason (OR
0.15, 95% CI 0.03 to 0.74, p¼0.019).
The HAND group performed consistently and signiﬁ-
cantly worse than the cognitively normal group across all
domains, except for the domain of orientation (table 3).
Impairment in the domains of delayed recall,
language, abstract thinking, motor speed and
Table 1 Demographic and clinical characteristics by neurocognitive status, N¼132
Normal, N[102 (77.3%) HAND, N[30 (22.7%) p Value
Age
Mean (years) 43.45 (SD¼10.19) 54.40 (SD¼10.83) <0.001
Education
Mean (years) 11.45 (SD¼3.97) 8.03 (SD¼3.66) <0.001
Employment (n, %)
Professional 40 (39.2%) 3 (10%)
Blue-collar 36 (35.3%) 13 (43.3%) 0.001
Unemployed 26 (25.5%) 14 (46.7%)
Gender (n, %)
Male 86 (84.3%) 28 (93.3%) 0.362
Female 16 (15.7%) 2 (6.7%)
Race (n, %)
Chinese 85 (83.3%) 28 (93.3%) 0.317
Malay 8 (7.8%) 0
Indian 6 (5.9%) 2 (6.7%)
Others 3 (2.9%) 0
Stage of illness at diagnosis (n, %)
A 62 (60.8%) 9 (30%) 0.006
B 8 (7.8%) 2 (6.7%)
C 32 (31.4%) 19 (63.3%)
Baseline CD4 (n, %)
<200 48 (47.5%) 24 (80.0%)
200e499 40 (39.6%) 2 (6.7%) 0.002
>500 13 (12.9%) 4 (13.3%)
Current CD4 (n, %)
<200 23 (22.8%) 8 (27.6%)
200e499 53 (52.5%) 16 (55.2%) 0.670
>500 25 (24.8%) 5 (17.2%)
Comorbid STI (n, %) 43 (42.2%) 15 (50.0%) 0.447
Comorbid vascular risk factor(s) (n, %) 38 (37.3%) 16 (53.3%) 0.115
STI, sexually transmitted infection.
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Application of HAND criteria in South Asian contextpsychomotor speed were prevalent in at least two-thirds
of the HAND group. The domains of visuospatial func-
tion, executive function and attention were affected
the least frequently. However, logistic regression showed
that impairment in visuospatial function, attention or
language on the MoCA was most predictive for the
presence of HAND (table 4).
DISCUSSION
Our study showed that one in ﬁve HIV-positive patients
from a South Asian population can be expected to have
HAND. The results indicate that patients with HAND
tend to be older (mean 54.4 years), with fewer years of
formal education (mean 8.0), and had extremely low
baseline CD4 counts (CD4 <200 cells/ml). This is
consistent with the previous studies.
20e22 Length of time
since diagnosis and current CD4 counts did not deter-
mine the diagnosis of HAND.
Other studies have not examined directly the associa-
tion between duration of illness and the presence of
neurocognitive impairment but have hypothesised that
central nervous system injury begins very early in the
course of HIV infection.
23 Also, recovery of immuno-
suppression does not appear to be protective for HAND,
a ﬁnding that has been recently demonstrated.
5 In our
study, HAND was directly related to severely low baseline
CD4 counts. The ﬁnding that nadir CD4 counts are
a strong predictor for HAND has been shown in several
studies.
12 0Because our study design is cross-sectional,
we are unable to assess the effect of immune recovery or
comment on nadir CD4 count. We assume that because
patients present with late-stage HIV infection, baseline
CD4 count is an approximate surrogate for nadir CD4
cell count.
Our study failed to show any statistically meaningful
relationship between HAND and sexually transmitted
infections, hepatitis B and C coinfection and vascular
risk factors, unlike previous studies.
24e28 This is most
likely due to a small number in the HAND group.
However, the effect of vascular risk factors would be an
Table 2 Association between listed factors and prevalent HAND
Variable OR (95% CI) p Value Adjusted OR (95% CI) p Value
Age (years) 1.104 (1.054 to 1.155) <0.001
Education (years) 0.782 (0.687 to 0.890) <0.001
Years since diagnosis 1.024 (0.940 to 1.116) 0.588
Stage at diagnosis
A (Reference)
B 1.722 (0.315 to 9.427) 0.531
C 4.090 (1.662 to 10.066) 0.002 1.333 (0.369 to 4.815) 0.661
Baseline CD4
<200 (Reference)
200e499 10.000 (2.226 to 44.919) 0.003 0.151 (0.031 to 0.737) 0.019
>500 0.437 (0.478 to 5.521) 0.437
Current CD4
<200 (Reference)
200e499 1.152 (0.433 to 3.069) 0.777
>500 1.739 (0.497 to 6.086) 0.387
History of CNS OIs 3.67 (0.70 to 19.21) 0.124
Log-transformed viral load 1.15 (0.94 to 1.40) 0.177
Vascular risk factors 1.92 (0.85 to 4.38) 0.118
Adjusted OR, corrected for age and education. CNS OIs, central nervous system opportunistic infections.
Table 3 Comparison of scores on cognitive tests by cognitive status
Score Normal, mean (SD) HAND, mean (SD) p Value
MoCA (total) 28.45 (1.45) 24.17 (3.20) <0.001
MoCA (executive function) 3.82 (0.41) 3.03 (1.03) <0.001
MoCA (attention) 5.95 (0.22) 5.63 (0.56) 0.004
MoCA (language) 5.71 (0.54) 4.50 (1.08) <0.001
MoCA (abstraction) 1.61 (0.55) 1.97 (0.67) <0.001
MoCA (recall) 4.23 (0.97) 3.23 (1.19) <0.001
MoCA (visuospatial) 0.93 (0.25) 0.40 (0.50) <0.001
MoCA (orientation) 5.93 (0.29) 5.73 (0.64) 0.109
IHDS (total) 10.92 (1.20) 8.65 (2.34) <0.001
IHDS (motor speed) 3.49 (0.82) 2.60 (1.30) 0.001
IHDS (psychomotor speed) 3.59 (0.75) 2.57 (1.33) <0.001
IHDS, International HIV Dementia Scale; MoCA, Montreal Cognitive Assessment.
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Application of HAND criteria in South Asian contextimportant area for future research as the baseline prev-
alence of metabolic diseases in Singapore is high.
29 Our
study also showed that a history of central nervous system
opportunistic infections is possibly an important
contributing factor despite the lack of statistical signiﬁ-
cance that we attribute to the small sample size, while
other studies had actively excluded such patients.
5 The
viral load in plasma was traditionally thought to predict
the presence of HIV-associated dementia
30 but more
recent studies have shown correlation with viral loads in
the cerebrospinal ﬂuid while there is peripheral viral
suppression.
53 1Currently, it is not local practice to
measure HIV RNA in the cerebrospinal ﬂuid and great
difﬁculties with getting consent for lumbar punctures
from future research subjects are anticipated.
HAND is currently conceptualised as having a subcor-
tical pattern
32 with an argument for bradykinesia and
bradyphrenia being the cardinal features of HAND.
33
There is also general agreement that the most prevalent
impairments in HIV are in the domains of Learning,
Abstraction/Executive Functioning, Attention/Working
Memory and Motor Functioning, whereas Verbal Func-
tioning/Language is relatively spared.
43 2The pattern of
cognitive impairment in South Asian patients with
HAND does not appear to ﬁt into a discrete subcortical
pattern as previously thought. In fact, both cortical and
subcortical functions are frequently affected, and this is
consistent with a recent study demonstrating both
cortical and subcortical neurodegeneration.
34 It is not
clear from this study whether this is due to effects of
HAART, as suggested by other studies.
35 Even though it
is possible to analyse the Central Nervous System Pene-
tration Effectiveness (CPE) scores
36 of the HAART
regime of the study subjects, the cross-sectional meth-
odology limits meaningful interpretation of the results as
many other confounders such as duration of treatment
and the timing of treatment initiation need to be
considered. Future longitudinal studies should evaluate
the differences in the cognitive proﬁle of HAND in
patients with and without HAART.
An important limitation of this study is the relatively
small sample size. However, previous prevalence esti-
mates were too imprecise for an a priori sample size
calculation. There was also potential response bias that
was not dealt with in the study methodology. Patients
who did not consent to participate in the study may have
had characteristics that would skew the prevalence rate
in either direction. This study is also limited by the lack
of published normative data on the cognitive tools used.
However, the authors have used demographically
appropriate data wherever possible. Another limitation
is the lack of exclusion of subjects with substance or
alcohol use. However, based on the demographics of the
local HIV population, substance or alcohol use is rela-
tively uncommon.
However, we feel that this study is important as it
provides the ﬁrst data we have among multiethnic South
Asian patients on HAND. Our centre sees the majority of
HIV/AIDS patients, and thus, the study prevalence likely
approximates the true prevalence of HAND in
Singapore. This study adds another compelling reason
for early diagnosis of HIV infection and linkage to care
and treatment.
Previous studies have used specially developed
neuropsychological batteries to detect and diagnose
HAND.
19 37e39 To the authors’ knowledge, this present
study is the ﬁrst to use a standardised mental status
examination (an acceptable option in the updated
research nosology for HAND considering resource-
limited contexts)
19 in a novel way of using domain-
speciﬁc performance in addition to recommended
cut-off scores, as well as using a combination of stand-
ardised mental status examinations to provide for an
assessment of a broad and comprehensive range of
cognitive functions. In most South Asian countries,
neuropsychological testing is available but mostly in non-
integrated settings. Hence, even though resources are
not limited, access to it is hindered by many cultural and
patient factors. Making clinical diagnoses of cognitive
impairment using a combination of clinical judgement
and brief bedside tools is the local practice. Thus, the
method of detection used in this study was chosen
because of its potential clinical utility. The authors
acknowledge that this methodology though novel
severely limits the study’s comparability with previous
studies. Yet it is commendable and worth commenting
that the results obtained are strikingly similar to data
previously published.
12
Table 4 Logistic regression results showing the predictive power of domain-speciﬁc impairment, N¼30
Cognitive domain Regression coefﬁcient 95% CI p Value
MoCA (visuospatial) 3.013 1.954 to 4.073 <0.001
MoCA (attention) 2.205 1.043 to 3.367 <0.001
MoCA (language) 1.989 1.247 to 2.731 <0.001
MoCA (abstraction) 1.637 0.895 to 2.379 <0.001
MoCA (executive function) 1.586 0.888 to 2.283 <0.001
MoCA (total) 1.065 0.671 to 1.458 <0.001
IHDS (psychomotor speed) 0.937 0.500 to 1.373 <0.001
IHDS (total) 0.802 0.467 to 1.138 <0.001
IHDS (motor speed) 0.791 0.378 to 1.205 <0.001
MoCA (recall) 0.791 0.384 to 1.200 <0.001
IHDS, International HIV Dementia Scale; MoCA, Montreal Cognitive Assessment.
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Application of HAND criteria in South Asian contextFurther research is essential in order to understand
the clinical importance of HAND and the proﬁle of its
longitudinal history in HIV-positive patients in South
Asia. Validation of the test instruments speciﬁcally using
HIV negative controls would add to the evidence base of
the clinical utility of such tools. Such tools are potentially
of immense use even in settings that are not resource
limited.
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